Dr. Vogelzang, MD, FASCO, FACP
Mesothelioma Specialist
Dr. Nicholas Vogelzang, MD, FASCO, FACP, dedicated his professional life to researching and treating rare forms of cancer. He revolutionized mesothelioma treatment by discovering the first life-extending treatment for the disease. This chemotherapy drug combination of ALIMTA and Cisplatin continues to be the standard of care today.
Dr. Vogelzang passed away in September 2022. He was truly a wonderful person and physician, transforming lives and giving hope to people all over the world.
Board Certified
Internal Medicine
Medical Oncology
Memberships
American Association of Cancer Research
American College of Physicians
American Society of Clinical Oncology
American Urological Association
Chicago Urological Society
Clark County Medical Society
European Society for Medical Oncology
International Association for the Study of Lung Cancer
Kidney Cancer Association
Mesothelioma Applied Research Foundation
Nevada Oncology Society
Society of Urologic Oncology
Dr. Vogelzang was a world-renowned oncologist in the field of mesothelioma
Dr. Vogelzang, MD, FASCO, FACP published over 100 articles on mesothelioma and was the co-author and co-editor of “Malignant Mesothelioma: Advances in Pathogenesis, Diagnosis, and Translational Therapies.” With hundreds of speaking engagements worldwide, he advocated advancing initiatives to eradicate mesothelioma.
